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INTRODUCTION
Withanolides are a group of natural C-28 steroids built on an ergostane skeleton and classified into two major groups according to their
structural skeleton: (a) compounds with a beta-oriented side chain and (b) compounds with a alpha-oriented side chain. Withanolide E
represents one of the members of the later group. Classification of active compounds on the basis of pharmacophore against specific
cancer cell line poses a serious concern at the primary stage of virtual screening. To overcome this problem we have developed an
artificial neural network based virtual screening model for discriminating active and non-active Withanolide-E like derivatives or analogs
against human breast cancer cell line MCF-7. In the present work, a 2D chemical descriptors ensemble pharmacophore has been
modelled on the basis of withanolide E structural featured molecules. The ANN structure activity based classification model could be
useful for identification of active withanolides analogs as anticancer leads against MCF-7. Model can be used for predicting possible
growth inhibitory concentration (logGI50) against breast cancer cell line MCF-7. The virtual screening tool “CanWithaANN” can be
accessed at local network of CIMAP.
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Establishing relationship between ‘Virtual Pharmacophore Consensus’ and ‘bioactivity’ at cell line level
RESULTS 
[http://192.168.17.28/canwithaann/indexx.html]
1. Web-application implementing model
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METHODOLOGY
Data (Molecules active against 
MCF-7 cell line)
Withanolide-E centered clustering 
or mapping 
(SOM / K-means)
2D-Descriptor calculation for 
molecules (PaDEL)
Descriptor selection (Correlation 
matrix / PCA)
ANN based SAR model for 
clustered molecules
Decision making for activeness of new 
coming Withanolide structures
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2. ANN model, capturing the ‘virtual Pharmacophore’ 
for Withanolide-E  against human breast cancer cell 
line MCF-7.
3. Clustered molecules (Analogs) other than 
Withanolide similar structures which participate 
actively against MCF-7.
4. Revealed unexplored Withanolide’s  active 
derivatives against MCF-7. -8.5
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Predicted Bioactivity (logGI50)
S.No. NCBI CID logGI50_M 
Target cell 
line 
1. 276293 -9.119 MCF-7 
2. 401678 -8.75 MCF-7 
3. 24202596 -8.112 MCF-7 
4. 388300 -8.02 MCF-7 
5. 122736 -8 MCF-7 
6. 407582 -7.886 MCF-7 
7. 282304 -7.785 MCF-7 
8. 314799 -7.823 MCF-7 
9. 4605 -7.788 MCF-7 
10. 390666 -7.725 MCF-7 
11. 286106 -7.624 MCF-7 
12. 222156 -7.602 MCF-7 
13. 373676 -7.475 MCF-7 
14. 222154 -7.523 MCF-7 
15. 417553 -7.426 MCF-7 
16. 417451 -7.382 MCF-7 
17. 222160 -7.426 MCF-7 
18. 3061 -7.384 MCF-7 
19. 281990 -7.301 MCF-7 
S.No. NCBI CID logGI50_M 
Target cell 
line 
21. 3879 -7.292 MCF-7 
22. 222159 -7.263 MCF-7 
23. 317839 -7.112 MCF-7 
24. 401955 -6.953 MCF-7 
25. 289842 -6.796 MCF-7 
26. 385532 -6.726 MCF-7 
27. 73621 -6.73 MCF-7 
28. 433361 -6.632 MCF-7 
29. 388098 -6.566 MCF-7 
30. 407583 -6.284 MCF-7 
31. 267360 -6.337 MCF-7 
32. 222155 -6.334 MCF-7 
33. 401302 -6.231 MCF-7 
34. 392623 -6.183 MCF-7 
35. 385534 -6.161 MCF-7 
36. 398800 -6.062 MCF-7 
37. 397889 -6.111 MCF-7 
38. 382983 -6.125 MCF-7 
39. 378635 -6.139 MCF-7 
40. 318696 -6.027 MCF-7 
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Evaluation of model developed
Server-side (WAMP) implementation 
of model developed
Web-application of model developed(php + 
mySQL), including user account management 
[http://192.168.17.28/canwithaann/indexx.html]
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Mapped Aromatase bonded ligand 
(Androstenedione) PDBID: 3EQM
20. 272581 -7.258 MCF-7 
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4beta-Hydroxywithanolide E 
(Mother compound)
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